17.78
+0.11
+(0.62%)
At close: January 21 at 5:32:06 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 3 | 2 | 14 | 14 |
Avg. Estimate | 3.6B | 3.85B | 15.12B | 15.21B |
Low Estimate | 3.53B | 3.82B | 15B | 14.58B |
High Estimate | 3.66B | 3.87B | 15.27B | 15.82B |
Year Ago Sales | 3.6B | 3.8B | 15.27B | 15.12B |
Sales Growth (year/est) | -0.16% | 1.35% | -0.93% | 0.58% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EVK.VI | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
Downgrade | Citigroup: Buy to Neutral | 11/16/2018 |
Related Tickers
600309.SS WANHUA CHEM
67.52
-1.75%
NVZMY Novonesis A/S
57.40
+2.43%
ORI.AX Orica Limited
16.93
+1.87%
CRBN.AS Corbion N.V.
23.22
+0.09%
1COV.DE Covestro AG
56.36
+0.04%
AVTX.AS Avantium N.V.
1.8360
-0.33%
GIVN.SW Givaudan SA
3,960.00
-0.08%
WCH.DE Wacker Chemie AG
64.80
-1.43%
VBK.DE Verbio SE
9.52
+4.91%
LIN.DE Linde plc
425.80
+0.71%